Literature DB >> 30036828

Fabrication of pure and moxifloxacin functionalized silver oxide nanoparticles for photocatalytic and antimicrobial activity.

Sirajul Haq1, Wajid Rehman2, Muhammad Waseem3, Vera Meynen4, Saif Ullah Awan5, Shaukat Saeed6, Naseem Iqbal7.   

Abstract

This paper reports the synthesis of silver oxide (Ag2O) and moxifloxacin functionalized silver oxide (M-Ag2O) nanoparticles for photocatalytic and antimicrobial activity. The Ag2O nanoparticles were synthesized by using 2 dimethyl amino ethanol as reducing agent. The BET surface area measured from N2 adsorption method was found to be 16.89 m2/g. The mix (cubic and hexagonal) phase of silver oxide (Ag2O) nanoparticles was confirmed by X-rays diffraction (XRD). The extra diffracted peaks were observed after moxifloxacin fictionalization. The scanning electron micrographs display spherical shaped particles of different sizes. The elemental composition and weight percent of both samples were studied by energy dispersive X-ray (EDX). The decrease in the weight percent of silver with the subsequent increase in the weight percent of carbon and oxygen revealed the successful loading of moxifloxacin onto Ag2O NPs. The two stages of weight loss due to the removal of physisorbed and chemisorbed water was examined during thermogravimetric analysis (TGA). The optical band gap derived from the diffuse reflectance spectrum (DRS) was 1.83 eV, which corresponds to the transmittance edge of 676 nm. The Fourier transform infrared (FTIR) band at 668.56 cm-1 confirms the successful synthesis of moxifloxacin functionalized silver oxide (Ag2O) nanoparticles. The pure Ag2O nanoparticles were used for the degradation of rhodamine 6G and 98.56% dye was degraded in 330 min. The bacterial species selected for the present study were Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus Niger. Both pure and functionalized Ag2O NPs were screened against selected bacterial and fungal species and they showed improved activity with the volume of samples taken in wells. However, the activity of Ag2O NPs against fungi was found less effective than bacteria which may be due to the difference in the composition of the cell wall. Further gram-positive bacteria showed more resistance toward both samples as compared to the gram-negative bacteria. It was concluded that Ag2O NPs upon conjugation with moxifloxacin displayed promising antimicrobial activity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial; Characterization; Moxifloxacin; Nanoparticles; Photocatalytic; Silver nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 30036828     DOI: 10.1016/j.jphotobiol.2018.07.011

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  5 in total

Review 1.  Silver chalcogenide nanoparticles: a review of their biomedical applications.

Authors:  Lenitza M Nieves; Katherine Mossburg; Jessica C Hsu; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2021-12-02       Impact factor: 7.790

Review 2.  Antimicrobial Properties of the Ag, Cu Nanoparticle System.

Authors:  Xinzhen Fan; L'Hocine Yahia; Edward Sacher
Journal:  Biology (Basel)       Date:  2021-02-10

Review 3.  Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation.

Authors:  Sergey V Gudkov; Dmitriy A Serov; Maxim E Astashev; Anastasia A Semenova; Andrey B Lisitsyn
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-05

4.  In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens.

Authors:  Amreen Shah; Isfahan Tauseef; Manel Ben Ali; Muhammad Arfat Yameen; Amine Mezni; Amor Hedfi; Syed Kashif Haleem; Sirajul Haq
Journal:  Toxics       Date:  2021-05-08

Review 5.  Biomaterials for the Prevention of Oral Candidiasis Development.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.